Ultragenyx Pharmaceutical reported $70K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Agios Pharmaceuticals AGIO:US USD 71K 0
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Aptinyx Inc APTX:US USD 677K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Esperion Therapeutics ESPR:US USD 72K 7K
Insmed INSM:US USD 1.22M 18K
Karyopharm Therapeutics KPTI:US USD 8K 0
Kyowa Hakko Kirin 4151:JP JPY 26.74B 0
Macrogenics MGNX:US USD 615K 0
Mirati Therapeutics MRTX:US USD 58K 2K
Moderna Inc MRNA:US USD 38.7K 500
Neurocrine Biosciences NBIX:US USD 100K 0
Ptc Therapeutics PTCT:US USD 71K 0
Sarepta Therapeutics SRPT:US USD 9K 0
Ultragenyx Pharmaceutical RARE:US USD 70K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0
Vital Therapies VTL:US USD 3K 0
Xoma XOMA:US USD 86K 0